While the majority of cancer immunotherapies focus on CD8+ T cells, considered as the key players in tumor defense, the potential role of CD4+ T helper cells has remained mostly unexamined, even if it is becoming clear that CD4+ T cells play a critical role in developing and sustaining effective anti-tumor immunity [32]. This evidence concerns the gene CD4 and cancer.